Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 12 - Number 4




VIP in Inflammatory Bowel Disease: State of the Art

, 12(4): 316 - 322

Catalina Abad, Rosa Gomariz, James Waschek, Javier Leceta, Carmen Martinez, Yasmina Juarranz and Alicia Arranz


DOI: 10.2174/187153012803832576








Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes

, 12(4): 377 - 381

Vincenzo Triggiani, Vito Angelo Giagulli, Angela Tafaro, Francesco Resta, Carlo Sabba, Brunella Licchelli and Edoardo Guastamacchia


DOI: 10.2174/187153012803832558




Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog